Status:
UNKNOWN
Online Cognitive Rehabilitation of Executive Dysfunction in Nonamnestic MCI
Lead Sponsor:
Baycrest
Collaborating Sponsors:
Centre for Aging and Brain Health Innovation
Conditions:
Nonamnestic Mild Cognitive Impairment
Cognitive Dysfunction
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Nonamnestic mild cognitive impairment (naMCI) is a prodromal state characterized by deficits in executive functioning, a collection of higher-order abilities involved in organization, planning, inhibi...
Eligibility Criteria
Inclusion
- Diagnosis of nonamnestic mild cognitive impairment
- Available to participate in all testing and intervention sessions
- Access to a computer
- Computer familiarity
- Normal or corrected-to-normal vision and hearing
Exclusion
- Diagnosis of amnestic mild cognitive impairment or dementia
- Moderate to severe affective impairment defined by score above cut-off for depression on the Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001)
Key Trial Info
Start Date :
August 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04503798
Start Date
August 20 2020
End Date
December 30 2021
Last Update
August 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baycrest Health Sciences
Toronto, Ontario, Canada, M6A2E1